Follow the Alivus Life Sciences Limited share price and the full insider trade history of the company, a listed issuer based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Alivus Life Sciences Limited has logged 8 public disclosures. Market capitalisation: €142.4bn. The latest transaction was disclosed on 15 July 2024 (Sale). Among the most active insiders: GLENN SALDANHA. All data is accessible without an account.
8
Insider Decl.
n/a
Thresholds
€162m
3 ops.
Buy Volume
€697m
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Alivus Life Sciences Limited Strong Buy (bullish), based on 4 analysts. Average price target: ₹1,245.00.
10Σ signal
Buys €162m€697m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,454 of 28,857 companies
65.4
score / 100
Value
46
Quality
85
FCF yld1.8%
Earn yld4.0%
EV/EBITDA17.2x
ROE18%
Gross mgn58%
Net mgn22%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.